| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q2 2022 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ISHARES TR NASDAQ BIOTECH | 11 | Q2 2020 | 11.4% |
| POWERSHARES EXCHANGE TRADED FD TR DYNAMIC PHARMACEUTICALS PORTFOLIO | 9 | Q2 2015 | 13.0% |
| ISHARES U.S. MEDICAL DEVICES ETF | 9 | Q2 2020 | 12.0% |
| POWERSHARES EXCHANGE TRADED FD TR II S&P SMALLCAP HEALTH CARE PORT | 8 | Q3 2018 | 16.2% |
| ISHARES U S HEALTHCARE PROVIDERS ETF | 8 | Q2 2020 | 12.9% |
| MARKET VECTORS ETF TRUST BIOTECH ETF | 8 | Q3 2015 | 10.5% |
| POWERSHARES EXCHANGE TRADED FD TR DYNAMIC SEMICONDUCTORS PORTFOLIO | 7 | Q4 2017 | 14.9% |
| ISHARES TR NA TEC SFTWR ETF | 7 | Q2 2020 | 14.6% |
| VANECK VECTORS ETF TR SEMICONDUCTOR ET | 7 | Q1 2018 | 8.4% |
| ISHARES RESIDENTIAL REAL ESTATE ETF | 6 | Q4 2019 | 17.7% |
View NIEMANN CAPITAL MANAGEMENT INC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2021-02-03 |
| 13F-HR | 2020-11-10 |
| 13F-HR | 2020-08-04 |
| 13F-HR | 2020-04-29 |
| 13F-HR | 2020-02-07 |
| 13F-HR | 2019-11-04 |
| 13F-HR | 2019-07-29 |
| 13F-HR | 2019-04-25 |
| 13F-HR | 2019-02-06 |
| 13F-HR | 2018-11-06 |
View NIEMANN CAPITAL MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.